Related Experiment Video
Updated: Apr 23, 2026
The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
Published on: June 30, 2014
Risk stratification and mitigation multiple sclerosis
Abstract:
The increasing availability of new agents to treat multiple sclerosis poses new challenges for clinicians who seek therapies that are both safe and effective for their patients. The introduction of additional effective therapies has been accompanied by the recognition of serious side effects. The clinician now must weigh both the benefits and risks of therapies to help patients decide which treatment best fits each patient׳s risk/benefit profile. An optimal selection of therapies relies on a complete understanding of the risks of therapies and the factors that may help evaluate and mitigate those risks. An individualized treatment approach that incorporates patient and disease factors is needed for each patient. In this review we present risk stratification and mitigation strategies of disease modifying agents for multiple sclerosis.
Insights
Managing multiple sclerosis (MS) requires balancing treatment benefits against risks. This review outlines strategies for risk stratification and mitigation of disease-modifying agents in MS care.
Area of Science:
- Neurology
- Immunology
Background:
- Multiple sclerosis (MS) treatment landscape is expanding with new disease-modifying agents.
- Effective MS therapies are associated with serious potential side effects.
- Clinicians face challenges in selecting optimal treatments based on patient-specific risk/benefit profiles.
Purpose of the Study:
- To review risk stratification strategies for disease-modifying agents in multiple sclerosis.
- To present mitigation approaches for managing adverse events associated with MS therapies.
- To support individualized treatment selection for patients with multiple sclerosis.
Main Methods:
- Literature review of current disease-modifying agents for multiple sclerosis.
- Analysis of reported safety profiles and adverse events.
- Synthesis of risk stratification and mitigation guidelines.
Main Results:
- Newer MS therapies offer improved efficacy but carry significant risks.
- Understanding patient-specific factors is crucial for risk assessment.
- Proactive risk mitigation strategies can enhance treatment safety.
Conclusions:
- Individualized treatment selection is paramount in managing multiple sclerosis.
- Comprehensive risk assessment and mitigation are essential for safe and effective MS therapy.
- This review provides a framework for clinicians to navigate the complexities of MS treatment options.
More Related Videos
10:46A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
Published on: December 9, 2015
05:44Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice
Published on: October 13, 2023
Related Concept Videos
01:19Multiple Sclerosis l: Introduction
01:25Strategies for Assessing and Addressing Confounding
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...